Standard BioTools Inc.
LAB
$0.67
$0.023.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.03% | 588.10% | 156.59% | -28.77% | -- |
| Total Depreciation and Amortization | -36.51% | -32.60% | -57.69% | 456.47% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.71% | -1,812.24% | 1,144.65% | 2.07% | -- |
| Change in Net Operating Assets | 639.78% | -6.37% | -485.90% | 104.41% | -- |
| Cash from Operations | 50.11% | -53.87% | 91.54% | 20.33% | 47.07% |
| Capital Expenditure | 81.77% | 88.72% | 85.93% | 60.71% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -134.84% | -971.80% | -124.81% | 79.76% | -- |
| Cash from Investing | -47.62% | 1,206.60% | -131.25% | 78.37% | -45.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -61.04% | -- | 42.10% | -100.00% | -- |
| Repurchase of Common Stock | -29.00% | -156.52% | -180.00% | -60.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -227.78% | 13.04% | 101.14% | -5,500.00% | 100.38% |
| Foreign Exchange rate Adjustments | -62.69% | -67.79% | 62.55% | 50.25% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.00% | 1,042.00% | 79.80% | 50.65% | 144.84% |